Featured Posts
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing.
Blog
The unseen costs of banning PBM-owned pharmacies in Tennessee
Tennessee lawmakers recently passed the FAIR Rx Act, which would bar companies from owning pharmacies while also operating a pharmacy benefit manager (PBM)…
Search Posts
News Release
FDA Too Slow to Approve New Medical Drugs and Devices
A new nationwide poll of cancer specialists sponsored by the Competitive Enterprise Institute finds many of them believe the FDA is too slow in approving…
Study
A National Survey of Oncologists Regarding The Food And Drug Administration
Full Document Available in PDF A National Survey…
News Release
Will California’s Senate Follow Assembly’s Lead And Pass Costly Auto Regulations?
Washington, D.C., April 26, 2002 — The California State Assembly has passed new regulations that could increase the cost of new cars and…
Washington Post
US Backs Pediatric Tests In Reversal on Drug Safety
Op-Eds
FDA Overreaches
Who could possibly oppose a pediatric-testing rule for drugs? For starters, physicians and parents who realize that while this rule is supposed to protect children,…
Washington Post